U.S. health officials are recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine as they investigate six reports of potentially dangerous blood clots.
U.S. recommends ‘pause’ for Johnson & Johnson vaccine in response to 6 clot reports
